A Test to Predict the Hemolytic Potential of Drugs in G6PD Deficiency - Related Studies

A Test to Predict the Hemolytic Potential of Drugs in G6PD Deficiency

This study has been suspended.

Study NCT00076323. Last updated on January 31, 2006. Information provided by Walter Reed Army Institute of Research (WRAIR)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Favism

2	Additional conditions recognized in this trial
		Glucosephosphate Dehydrogenase Deficiency
		Glycogen Storage Disease Type I

3	More general conditions related to this trial
		Anemia
		Anemia, Hemolytic
		Anemia, Hemolytic, Congenital
		Carbohydrate Metabolism, Inborn Errors
		Disorders of Environmental Origin
		Food Poisoning
		Genetic Diseases, Inborn
		Glycogen Storage Disease
		Hematologic Diseases
		Metabolic Diseases
		Metabolism, Inborn Errors
		Plant Poisoning
		Poisoning

4	Interventions listed in this trial
		Primaquine

5	More general drug interventions related to this trial
		Anti-Infective Agents
		Antimalarials
		Antiparasitic Agents
		Antiprotozoal Agents
		Pharmacologic Actions
		Therapeutic Uses

6	Sponsors listed in this trial
		Walter Reed Army Institute of Research (WRAIR)